It is also likely that the formation of certain of the metabolites described above would be associated with changes in lipid and/or fatty acid metabolism, either by depleting the tissues of an essential intermediate or by disturbance of the normal allosteric and feedback regulation of lipid synthesis and catabolism. Although very little is known about the possible biochemical mechanisms of these processes, it appears likely that the formation of many of the novel metabolites of carboxylic acids involves their acyl-CoA thioesters (Caldwell, 1984). The potential of these to disrupt normal lipid metabolism is considerable (Sherratt, 1985).
BIOCHEMICAL SOCIETY TRANSACTIONS
It is also likely that the formation of certain of the metabolites described above would be associated with changes in lipid and/or fatty acid metabolism, either by depleting the tissues of an essential intermediate or by disturbance of the normal allosteric and feedback regulation of lipid synthesis and catabolism. Although very little is known about the possible biochemical mechanisms of these processes, it appears likely that the formation of many of the novel metabolites of carboxylic acids involves their acyl-CoA thioesters (Caldwell, 1984) . The potential of these to disrupt normal lipid metabolism is considerable (Sherratt, 1985) .
The normal functioning of living cells depends to a large extent upon normal function of various membranes. Lipidrelated xenobiotic conjugates, notably the hybrid triglycerides and the cholesteryl esters, have the potential to enter membranes and alter membrane structure by their steric effects. This could in turn modify membranedependent processes, either by altered structure or by slowing the deacylation-reacylation cycling of fatty acid residues within the membrane. It is of particular interest to note that the formation of the cholesteryl ester of IPCA after the administration of fenvalerate is apparently responsible for the granulomatous changes seen in the liver and certain other organs. The granulomas contain the cholesteryl ester in high concentration, and administration of the synthetic ester at a dose of 10mg/kg for as short a time as 7 days resulted in the appearance of granulomas in mouse liver (Miyamoto et al., 1985) .
In conclusion, it is clear that the application of modern analytical techniques to tissue residues of xenobiotics and to highly non-polar metabolites in the excreta has succeeded in revealing the occurrence of new types of conjugates, related in various ways to processes of lipid biochemstry. At the present time, the significance of these various types of reactions lies very much in the area of speculation. However, in view of toxicological concern about many compounds which give rise to these novel metabolites, and the failure of 'conventional' metabolic studies to shed light upon such problems, it is important that the potential implications of these reactions be borne in mind in such cases. Some of the clearest evidence for interactions between xenobiotic metabolism and lipid biochemistry has been gained in the last few years from drug and pesticide metabolism studies which have afforded examples of xenobiotic lipids. The identification of these metabolites requires the combined use of radiolabelled substrates, sophisticated separation technology and sensitive spectroscopic techniques. Increasing access to this technology is generating a steady flow of examples and, currently, the important classes of neutral xenobiotic lipids are (i) triacylglycerols, (ii) acylcholesterols and (iii) fatty acid esters (Hutson, 1982; Schooley & Quistad, 1983) . The more polar lipids such as phospholipids and bile acid conjugates also have their xenobiotic analogues (Schooley & Quistad, 1983) . With the notable exception of work on the mode of action of the hypolipidaeinic agents (Fears et al., 1978) , discoveries of xenobiotic lipids in vivo have been incidental to other objectives and, therefore, unexpected. Consequently, the drug/pesticide metabolism scientist has been forced to consider the significance of these novel metabolites. Xenobiotic lipids may have pharmacological and toxicological consequences in three ways: (i) via their presence as possibly persistent residues in tissues, (ii) via the action of intermediates associated with their formation or breakdown, or (iii) via the release of stored xenobiotic residues. Some problems deriving from their possible persistence in tissues are, in principle, the same as those posed by any persistent lipophilic xenobiotic. The very presence of a xenobiotic stored in tissue is perceived as a problem, particularly when derived from non-therapeutic agents, even if the chemical is without obvious action. Problems specific to xenobiotic lipids may arise via the disturbance of lipid metabolism and, with membrane lipids, via altered membrane function. It is appropriate, therefore, to consider first the observed rates of clearance of some of these metabolites from the body. The hybrid triacylglycerols do not appear to pose a particular problem in this respect. 3-Phenoxybenzoic acid (3PBA) when dosed orally t o rats 612th MEETING, LONDON (0.76 mg/kg) affords a residue in skin amounting t o I-3% of the dose. This residue was purified t o yield a mixture of 3-phenoxybenzoyl dipalmitins (Crayford & Hutson, 1980) . We have recently measured the rate of depletion of 3 PBAderived metabolites from the skin and fat of rats after 7 daily doses of [14C] 3PBA ( 7 x 81 mg/kg). The results showed that the metabolites were eliminated from the body with half-lives of 10 days in abdominal fat, 7 days in skin and 7 days in subcutaneous fat. Cyclopropanecarboxylic acid (CPCA), derived from the metabolism o f the miticide cycloprate, is similarly incorporated into triacylglycerols (after chain elongation t o w-cyclopropyl fatty acids). These metabolites are also eliminated at a rate similar t o that of natural fatty acids (Quistad er al., 1978a) . The latter has been quoted variously at 8 days, 9 days or 16-20 days (references in Quistad er al., 1978a) . Thus it would appear that the few xenobiotic triacylglycerols studied in this way are catabolized at rates similar to those of their natural analogues.
Cholesteryl esters of xenobiotic acids may have longer half-lives than those of xenobiotic triacylglycerols, although there is as yet no general evidence for this. Fears er al. ( 1982) . describing the cholesteryl ester of 1 -(4'-carboxy- (CCD) formed by the rat during dietary administration of CCD for 7 days (equivalent t o 250 mg/kg), stressed that the conjugate was localized in the liver. Thus it accumulated a t the site of biosynthesis, did not circulate on lipoproteins and was not metabolized by lysosomal cholesteryl ester hydrolase. This ester (n1.p. 108 C) is thought t o lack fluidity in lipid phases in comparison with the linoleate (m.p. 42°C) and the oleate esters (n1.p. 45°C). CCD is a hypolipidaemic agent. Cholesteryl ester formation may be involved in its mode of action as the ester enhances the rate of hydrolysis of natural cholesteryl esters, a process important in the clearance of low-density lipoproteins. Acidic metabolites of the insect growth-regulatory methoprene (Quistad er al., 1976 ) and of the miticide cycloprate (Quistad et al., 1978a) also form cholesteryl esters in low yield in tissues. Given the right combination of biostability and physical properties, cholesteryl esters could crystallize in tissue giving rise t o foci similar t o the 'cholesterol clefts' reported in sonie hyperlipidaeniic conditions.
phenoxy)-lO-(4"-chlorophenoxy)-decane
Another consequence of the presence of persistent metabolites in mamnialian liver may be that of monooxygenase induction. This is associated (not necessarily causally) with hyperplasia and an increased incidence of liver tuniours in the mouse (Wright et al., 1972) . A knowledge of these relationships may serve t o avoid the demise of a useful chemical on grounds of inappropriate carcinogenicity data. To illustrate the potential complexity of xenobiotic-lipid relationships, the role of diacylglycerols in cell signalling may be cited. The tumour-promoting phorbol esters have been postulated t o be mimics for the diacylglycerols which transiently activate protein kinase C (Nishiuka. 1984) . This enzyme appears t o play a crucial role in signal transduction between cells and their environments. Xenobiotic diacylglycerols could similarly substitute for the natural analogues, producing a permanently activated enzyme and resultant undesirable consequences.
Xenobiotic lipids per se could also conceivably alter membrane stability and function. Xenobiotic phospholipids have been reported (Schooley & Quistad, 1983) , but mostly at sites of high biosynthetic activity, e.g. liver and egg yolk. Their occurrence in nervous tissue would seem to be a niore serious potential problem. However, we have found that rats receiving high doses of 3 PBA afforded no biochemical evidence of nerve cell damage (as indicated by ruptured 1 y so so tiles).
Consequences of the conjugation of xenobiotics with Vol. 13 lipids may derive from interactions of intermediates associated with their formation. Most speculation has centrcd around tlic intermediacy of the xenobiotic acylCoA esters. One of the first discoveries of xenobiotic triacylglycerols was by Fears et al. (1978) , who were studying the mode of action of the hypolipidaemic agent ethyl-4-benzyloxybenzoate. The association between the pharmacological action and glyceride formation seemed unlikely t o be coincidental. The action may involve the inhibition of acetyl-CoA carboxylase by the xenobioticCoA derivative, depleting malonyl-CoA and reducing fatty acid synthesis (McCune et al., 1982) . Alternatively, coenzyme A may be sequestered and its availability for lipogenenesis be restricted (Fears & Richards, 1981) . It is also possible that xenobiotic CoA esters may compete with natural acyl-CoAs for the acyltransferases. Thus the active forms of these drugs may be their CoA esters. An interesting interaction reported by Quistad er al. (1 978b) for the miticide cycloprate concerns fatty acid transport, Carnitine is crucial in lipid biochemistry as the carrier of fatty acyl groups across the inner mitochondria1 membrane. However, when the cyclopropanecarboxylic acid moiety of cycloprate 0-acylates carnitine, the resultant 'conjugate' is relatively stable; it is excreted by rat and cow (also in milk). It accounts for 14% of a dose of cycloprate in the urine of treated dogs and approx. 30% of the dose is found as this material in the muscle 4 days after a single oral dose of cycloprate (0.7 mg/kg). The reaction is thought t o be responsible for the greater sensitivity of the dog (cf. rat) in subacute toxicity studies with the miticide. Furthermore, the selective ovicidal activity of cycloprate in mites may result from the sequestration of carnitine causing the inhibition of fatty acid transport and disruption of lipid utilization (Quistad et al., 1979) .
Effects consequent upon the metabolism of xenobiotic lipids will depend on the concentration of the metabolite in tissue, its location, its rate of hydrolysis and on the bioactivity of the xenobiotic moiety. Pharmacologically active carboxylic acids stored as diacyl-and triacyl-glycerols and as cholesteryl esters whould be expected t o exert their effects if rapid lipid mobilization were t o occur. Such esters may offer the possibility of slow-release of delayedrelease drug formulations. Fatty acid conjugates of xenobiotic alcohols have a similar potential for release of active material. Cannabis-related metabolites are retained in tissues by this mechanism. As 1 1 -hydroxy-A'-tetrahydrocannabinol possesses psychotomimetic activity, it has been suggested (Leighty el al., 1976 ) that this storage rnechanism, coupled with esterase-(or lipase-) catalysed hydrolysis, could account for persistent effects in some individuals using marihuana. Similarly, phencyclidine ('angel dust'), a drug of wide-spread abuse, is converted t o hydroxylated metabolites which have been shown (in vitro) t o be conjugated with fatty acids (Leighty & Fentiman, 1980) . As the alcohols are pharmacologically active, their storage in this mode could account for the persistent effects of this drug.
The major potential problems associated with xenobiotic lipids would seem t o be altered membrane function, e.g. nerve conduction, and receptor function, and their involvement in peroxisome proliferation (Lake & Gray, 1985) . It should be stressed, however, that there is no good evidence for nervous system malfunction caused by drugs etc. operating in this way. Important uses of xenobiotic lipid formation lie in the areas of hypolipidaemic drugs, slow-release and delayed-release formulations, targeting of drugs and probes for the study of lipid metabolism. Finally, the knowledge of their existence affords another weapon in the search for biochemical expIanations t o observed effects in high-dose toxicology.
